Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 23;10(21):4881.
doi: 10.3390/jcm10214881.

Evaluation of the Efficacy and Safety of Canaloplasty and iStent Bypass Implantation in Patients with Open-Angle Glaucoma: A Review of the Literature

Affiliations
Review

Evaluation of the Efficacy and Safety of Canaloplasty and iStent Bypass Implantation in Patients with Open-Angle Glaucoma: A Review of the Literature

Kinga Gołaszewska et al. J Clin Med. .

Abstract

The aim of the paper was to evaluate the efficacy and safety of minimally invasive antiglaucoma procedures: Canaloplasty and iStent bypass implantation with and without phacoemulsification in patients with primary open-angle glaucoma (POAG). A systematic review of the recent literature was performed based on the PubMed, Google Scholar, Web of Science and Scopus databases. The effectiveness of the procedures was evaluated based on the reduction of intraocular pressure (IOP) and the amount of antiglaucoma medication used before and after surgery. Safety of the treatments was evaluated based on the number of incidences of certain intraoperative and postoperative complications. Independent prospective randomized controlled trials (PRCTs) have demonstrated that both procedures, canaloplasty and iStent implantation, are effective in reducing IOP and the amount of antiglaucoma medication. Considering the safety profile of these procedures, both canaloplasty and iStent implantation are associated with low rates of postoperative complications and have similar safety profiles. Further studies are needed to confirm the results of our analysis, including a high-quality randomized controlled trial comparing canaloplasty and iStent bypass implantation.

Keywords: canaloplasty; iStent; intraocular pressure; minimally invasive glaucoma surgery; phacocanaloplasty; phacoemulsification with iStent; primary open angle glaucoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart of study selection process.

Similar articles

Cited by

References

    1. Tham Y.C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090. doi: 10.1016/j.ophtha.2014.05.013. - DOI - PubMed
    1. Spaeth G.L., Lopes J.F., Junk A., Grigorian A.P., Henderer J. Systems for Staging the Amount of Optic Nerve Damage in Glaucoma: A Critical Review and New Material. Surv. Ophthalmol. 2006;51:293–315. doi: 10.1016/j.survophthal.2006.04.008. - DOI - PubMed
    1. The Advanced Glaucoma Intervention Study (AGIS): The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am. J. Ophthalmol. 2000;130:429–440. doi: 10.1016/S0002-9394(00)00538-9. - DOI - PubMed
    1. Saheb H., Ahmed I.I. Micro-invasive glaucoma surgery: Current perspectives and future directions. Curr. Opin. Ophthalmol. 2012;23:96–104. doi: 10.1097/ICU.0b013e32834ff1e7. - DOI - PubMed
    1. Caprioli J., Kim J.H., Friedman D.S., Kiang T., Moster M.R., Parrish R.K., Rorer E.M., Samuelson T., Tarver M.E., Singh K., et al. Special commentary: Supporting innovation for safe and effective minimally invasive glaucoma surgery: Summary of a Joint Meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology. 2014;122:1795–1801. doi: 10.1016/j.ophtha.2015.02.029. - DOI - PubMed

LinkOut - more resources